Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia 2022-07-04 22:14
Abbisko Therapeutics Completed Dosing of First Patient for Its First-in-Class Highly Selective FGFR2/3 Inhibitor ABSK061 2022-07-04 13:34
ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer 2022-07-01 22:00
Bon Natural Life Limited Announces Change to Board Composition 2022-07-01 04:30
Fosun's Businesses Shows Strong Recovery Momentum as Consumption Regains Vitality and Tourism Industry Continues to Recover 2022-06-30 20:16
Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918 2022-06-30 10:41
Infobird Co., Ltd Provides Digital and Intelligent Customer Engagement Solution to Enhance Patient Vaccination Notification Services for a Top-10 Global Pharmaceutical Company's Subsidiary 2022-06-29 20:30
Akeso's Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in China 2022-06-29 20:14
Supporting Communities and Sharing Happiness, 28 Liberty Successfully Hosts Multiple Community Events at New York's Fosun Plaza 2022-06-29 09:00
iNtRON to Seek a New Clinical Partner for SAL200 Endolysin 2022-06-28 21:00
Sanofi Enters into a Partnering Agreement with Health2Sync 2022-06-28 11:00
Harbour BioMed Announces IND Clearance for B7H4x4-1BB Bispecific Antibody by the U.S. Food and Drug Administration 2022-06-27 19:04
Amcor Lift-Off initiative shortlists start-ups for seed funding 2022-06-27 17:03
Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application 2022-06-26 08:00
Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D 2022-06-25 08:00
Stryker's debut at World Intelligence Congress: Bringing Stryker's Advanced Digital Healthcare to China 2022-06-24 23:00
Daewoong Pharmaceutical begins multinational phase 2 clinical trial for DWN12088, a new drug for idiopathic pulmonary fibrosis 2022-06-24 21:00
USANA Malaysia Named No. 1 Combination Dietary Supplements Brand by Euromonitor International 2022-06-24 10:00
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy 2022-06-23 23:00
Viva Biotech Successfully Held The 3rd Annual Partnership Summit 2022-06-23 20:30
1 140 141 142 143 144 801